SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-040666
Filing Date
2019-11-06
Accepted
2019-11-06 07:17:04
Documents
113
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q hznp-10q_20190930.htm   iXBRL 10-Q 5573516
2 EX-10.1 ex101.htm EX-10.1 113819
3 EX-10.2 ex102.htm EX-10.2 20945
4 EX-10.3 ex103.htm EX-10.3 85100
5 EX-31.1 hznp-ex311_724.htm EX-31.1 16077
6 EX-31.2 hznp-ex312_723.htm EX-31.2 15839
7 EX-32.1 hznp-ex321_722.htm EX-32.1 8967
8 EX-32.2 hznp-ex322_721.htm EX-32.2 8930
  Complete submission text file 0001564590-19-040666.txt   19280141

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA hznp-20190930.xsd EX-101.SCH 108640
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hznp-20190930_cal.xml EX-101.CAL 86061
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hznp-20190930_def.xml EX-101.DEF 441672
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE hznp-20190930_lab.xml EX-101.LAB 728797
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hznp-20190930_pre.xml EX-101.PRE 656730
25 EXTRACTED XBRL INSTANCE DOCUMENT hznp-10q_20190930_htm.xml XML 4214988
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Therapeutics Public Ltd Co (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35238 | Film No.: 191195062
SIC: 2834 Pharmaceutical Preparations